These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18465303)

  • 1. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
    J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
    Katas H; Cevher E; Alpar HO
    Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
    Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
    Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
    Bozdag S; Dillen K; Vandervoort J; Ludwig A
    J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles.
    Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM
    J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
    Lane ME; Brennan FS; Corrigan OI
    Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
    Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
    Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
    Kim BS; Kim CS; Lee KM
    Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
    Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL
    Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs.
    Joung YK; Choi JH; Park KM; Park KD
    Biomed Mater; 2007 Dec; 2(4):269-73. PubMed ID: 18458485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.